High-Throughput Screening Market Is Expected To Witness A CAGR Of 7.82% By 2030

The global high-throughput screening market size was around USD 18.93 billion in 2021 and is projected to grow to around USD 36.84 billion by 2030, with a compounded annual growth rate (CAGR) of roughly 7.82% from 2022 to 2030.

High-throughput screening is the scientific method that uses automation, miniaturized assays, and data analysis tools to run millions of biochemical, genetic, or pharmacological tests in parallel to find active compounds, genes, or antibodies. These screening technologies are used to speed up drug discovery and biological research. The latest systems now have artificial intelligence, microfluidics, and better imaging. Advancements in lab-on-a-chip technology and robotic liquid handling enhance precision, scalability, and efficiency in high-throughput screening applications.

Browse the full “High-Throughput Screening Market By Product And Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services), By Technology (Cell-Based Assays, Lab-On-A-Chip, Label-Free, 2D Cell Culture, 3D Cell Culture, and Bioinformatics), By Application (Target Identification and Validation, Drug Discovery, Primary and Secondary Screening, Toxicology Assessment, and Others), By End User (Pharmaceutical and Biotechnology Industries, Contract Research Organizations, Academic and Government Institutes, and Others) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2030”- Report at https://www.zionmarketresearch.com/report/high-throughput-screening-market

The focus on accelerated drug development and personalized medicine drives the market.

Market Growth Factors

Several factors contribute to the expansion of the high-throughput screening market.

• Drug discovery demands: Pharmaceutical companies are adopting high-throughput screening to speed up the search for new medicines.
• Research funding: Increased investment in life sciences is helping improve screening technology and expand its use.
• Disease complexity: The need for advanced screening technologies is growing as pharmaceutical companies target challenging therapeutic areas like cancer, neurological disorders, and rare diseases.

Restraints

• Equipment costs: High capital expenditure requirements create barriers for smaller research organizations.
• Assay standardization: Challenges in developing reproducible protocols across diverse screening platforms limit efficiency.

High-Throughput Screening Market Report Scope:

Market Segmentation

The high-throughput screening market can be segmented into technology, application, end-user, and region.

Based on technology, the market is segregated into cell-based assays, lab-on-a-chip, ultra-high-throughput screening, and label-free technology. Cell-based assays lead the market due to their physiological relevance, versatility across therapeutic areas, and capacity to identify compounds with favorable toxicity profiles early in discovery processes.

Based on application, the high-throughput screening industry is segmented into target identification, primary screening, toxicology, and stem cell research. Primary screening leads the market due to its critical position in drug discovery workflows and the substantial resources pharmaceutical companies allocate to initial compound evaluation.

Based on end-users, the high-throughput screening industry is classified into pharmaceutical companies, biotechnology companies, academic research institutes, and contract research organizations. Pharmaceutical companies are expected to lead the market during the forecast period since they maintain extensive discovery programs with substantial investment capacity for implementing cutting-edge screening technologies.

North America leads the global high-throughput screening market due to the massive research infrastructure and pharmaceutical presence in the US. The region’s dominance is mainly due to sizeable pharmaceutical investment programs and the presence of technology providers. A strong academic research base and funding mechanisms make North America strong in screening innovations. Ongoing precision medicine initiatives and biologics development are driving the market growth in the region. Collaboration between pharmaceutical companies, technology providers, and institutions is accelerating the development and deployment of next-generation screening platforms in North America.

Key Market Players

Some key industry players operating in the global high-throughput screening market include:

• Agilent Technologies Inc
• Danaher Corporation
• Perkinelmer Inc.
• Thermo Fisher Scientific Inc
• Axxam S.P.A
• Tecan Group Ltd
• Bio-Rad Laboratories Inc.
• Hamilton Company
• Sigma-Aldrich Corporation
• Charles River Laboratories International Inc.
• Merck KGaA
• Corning Incorporated
• BioTek Instruments Inc.
• Aurora Biomed Inc.
• General Electric
• Beckman Coulter Inc.
• Luminex Corporation
• AstraZeneca

Recent Developments

• In 2024, Thermo Fisher Scientific introduced an integrated AI-driven high-throughput screening platform capable of autonomous experimental design, real-time data analysis, and predictive modeling to accelerate lead compound identification.
• In 2024, PerkinElmer launched a next-generation microfluidic screening system that reduces reagent consumption by 90% while increasing throughput capabilities to over 100,000 compounds daily with enhanced sensitivity parameters.

The global high-throughput screening (HTS) market is segmented as follows:

By Application

• Target Identification and Validation
• Drug Discovery
• Primary and Secondary Screening
• Toxicology Assessment

By Technology

• Cell-Based Assays
• Lab-On-A-Chip
• Label-Free
• 2D Cell Culture
• 3D Cell Culture
• Bioinformatics

By Product and Service

• Reagents & Assay Kits,
• Instruments,
• Consumables & Accessories
• Software
• Services

By End User

• Pharmaceutical and Biotechnology Industries
• Contract Research Organizations
• Academic and Government Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com